Načítá se...
Role of sodium glucose co-transporter 2 inhibitors in patients with heart failure: an elusive mechanism
Heart failure (HF) is a major cause of morbidity and mortality worldwide, and the burden of HF continues to rise. There has been an interest in sodium-glucose co-transporter-2 (SGLT2) inhibitors for their role in reducing HF hospitalizations in pivotal trials. Since these agents were approved by the...
Uloženo v:
| Vydáno v: | Ann Med |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Taylor & Francis
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7877993/ https://ncbi.nlm.nih.gov/pubmed/32393068 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/07853890.2020.1767298 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|